Portal de Periódicos da CAPES

Hematopoietic cell therapy and transfusion medicine—carpe diem?

1995; Wiley; Volume: 35; Issue: 5 Linguagem: Inglês

10.1046/j.1537-2995.1995.35595259144.x

1537-2995

Edward L. Snyder,

CAR-T cell therapy research

TransfusionVolume 35, Issue 5 p. 371-373 Free Access Hematopoietic cell therapy and transfusion medicine—carpe diem? Edward L. Snyder MD, FACP, Edward L. Snyder MD, FACP Blood Bank, CB 459 Yale-New Haven Hospital 20 York Street New Haven, CT 06504Search for more papers by this author Edward L. Snyder MD, FACP, Edward L. Snyder MD, FACP Blood Bank, CB 459 Yale-New Haven Hospital 20 York Street New Haven, CT 06504Search for more papers by this author First published: May 1995 https://doi.org/10.1046/j.1537-2995.1995.35595259144.xCitations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 HG Klein, ed. Standards for blood banks and transfusion services. 16th ed. Bethesda: American Association of Blood Banks, 1994. Google Scholar 2 Kessler DA, Siegel JP, Noguchi PD, Zoon KC, Feiden KL, Woodcock J. Regulation of somatic-cell therapy and gene therapy by the Food and Drug Administration. N Engl J Med 1993; 329: 1169–73. 10.1056/NEJM199310143291607 CASPubMedWeb of Science®Google Scholar 3 Application of current statutory authorities to human somatic cell therapy products and gene therapy products. Federal Register 1993; 58 (Oct 14): 53248–251. Google Scholar Citing Literature Volume35, Issue5May 1995Pages 371-373 ReferencesRelatedInformation